Literature DB >> 2030376

Retinal migraine, chorea, and retinal artery thrombosis in a patient with primary antiphospholipid antibody syndrome.

J A Gutrecht1, N Kattwinkel, M J Stillman.   

Abstract

We report the case of a patient with the unusual combination of migraine, chorea, and retinal arterial thrombosis along with laboratory evidence of autoimmunity. In the absence of systemic lupus erythematosus, the clinical manifestations suggest the presence of the primary antiphospholipid antibody syndrome.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2030376     DOI： 10.1007/bf00319714

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  13 in total

1.  Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

Authors:  D Alarcón-Segovia; M Delezé; C V Oria; J Sánchez-Guerrero; L Gómez-Pacheco; J Cabiedes; L Fernández; S Ponce de León
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

2.  Chorea and the lupus anticoagulant.

Authors:  J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

3.  Antiphospholipid antibodies and chorea.

Authors:  R A Asherson; G R Hughes
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

Review 4.  Antiphospholipid antibodies.

Authors:  S R Levine; K M Welch
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

5.  Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies.

Authors:  J Jonas; K Kölble; H E Völcker; J R Kalden
Journal:  Am J Ophthalmol       Date:  1986-07-15       Impact factor: 5.258

6.  Lupus anticoagulant, antiphospholipid antibodies and migraine.

Authors:  M J Hogan; D G Brunet; P M Ford; D Lillicrap
Journal:  Can J Neurol Sci       Date:  1988-11       Impact factor: 2.104

7.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

8.  Cerebrovascular ischemia associated with lupus anticoagulant.

Authors:  S R Levine; K M Welch
Journal:  Stroke       Date:  1987 Jan-Feb       Impact factor: 7.914

9.  Neurological disease associated with antiphospholipid antibodies.

Authors:  D P Briley; B M Coull; S H Goodnight
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

10.  Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors:  R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965
View more
  3 in total

1.  Comment on the paper: Batchelor TT, Platten M, Palmer-Toy DE, Hunter GJ, Lev MH, Dalmau J, Hochberg FH: Chorea as a paraneoplastic complication of Hodgkin's disease. Journal of Neuro-Oncology 36: 185-190, 1998.

Authors:  J G Heckmann; C J Lang; B Neundörfer
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Authors:  Mohammad Hassan A Noureldine; Ali A Haydar; Ahmad Berjawi; Rody Elnawar; Ahmad Sweid; Munther A Khamashta; Graham R V Hughes; Imad Uthman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  Chorea and retinal vessel occlusion in a patient with systemic lupus erythematosus.

Authors:  Vahid-Reza Ostovan; Askar Ghorbani
Journal:  Iran J Neurol       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.